Targeted co-delivery biomimetic nanoparticles reverse macrophage polarization for enhanced rheumatoid arthritis therapy

References

• Barnes PJ. (1998). Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 94:557–72.
   PubMed Web of Science ®Google Scholar
• Baschant U, Lane NE, Tuckermann J. (2012). The multiple facets of glucocorticoid action in rheumatoid arthritis. Nat Rev Rheumatol 8:645–55.
   PubMed Web of Science ®Google Scholar
• Blanco E, Shen H, Ferrari M. (2015). Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol 33:941–51.
   PubMed Web of Science ®Google Scholar
• Brand DD, Latham KA, Rosloniec EF. (2007). Collagen-induced arthritis. Nat Protoc 2:1269–75.
   PubMed Web of Science ®Google Scholar
• Briggs J, Chamboredon S, Castellazzi M, et al. (2002). Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells. Oncogene 21:7077–91.
   PubMed Web of Science ®Google Scholar
• Castillo P, Kolls JK. (2016). IL-10: a paradigm for counterregulatory cytokines. J Immunol 197:1529–30.
   PubMed Web of Science ®Google Scholar
• Chen Q, Chen J, Liang C, et al. (2017). Drug-induced co-assembly of albumin/catalase as smart nano-theranostics for deep intra-tumoral penetration, hypoxia relieve, and synergistic combination therapy. J Controlled Release 263:79–89.
   PubMed Web of Science ®Google Scholar
• Chen T, Wang RT, Wang Z, et al. (2010). Construction and evaluation of non-specific targeting cationic polymer lipid liposomes. Yao Xue Xue Bao 45:359–64.
   PubMedGoogle Scholar
• Crielaard BJ, Rijcken CJ, Quan L, et al. (2012). Glucocorticoid-loaded core-cross-linked polymeric micelles with tailorable release kinetics for targeted therapy of rheumatoid arthritis. Angew Chem Int Ed Engl 51:7254–8.
   PubMed Web of Science ®Google Scholar
• Degboé Y, Rauwel B, Baron M, et al. (2019). Polarization of rheumatoid macrophages by TNF targeting through an IL-10/STAT3 mechanism. Front Immunol 10:3.
   PubMed Web of Science ®Google Scholar
• Derosa CA, Furusato B, Shaheduzzaman S, et al. (2012). Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression. Prostate Cancer Prostatic Dis 15:150–6.
   PubMed Web of Science ®Google Scholar
• Fickenscher H, Hör S, Küpers H, et al. (2002). The interleukin-10 family of cytokines. Trends Immunol 23:89–96.
   PubMed Web of Science ®Google Scholar
• Fosgerau K, Hoffmann T. (2015). Peptide therapeutics: current status and future directions. Drug Discov Today 20:122–8.
   PubMed Web of Science ®Google Scholar
• Ip WKE, Hoshi N, Shouval DS, et al. (2017). Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science 356:513–9.
   PubMed Web of Science ®Google Scholar
• Jain S, Tran TH, Amiji M. (2015). Macrophage repolarization with targeted alginate nanoparticles containing IL-10 plasmid DNA for the treatment of experimental arthritis. Biomaterials 61:162–77.
   PubMed Web of Science ®Google Scholar
• Karami E, Behdani M, Kazemi-Lomedasht F. (2020). Albumin nanoparticles as nanocarriers for drug delivery: focusing on antibody and nanobody delivery and albumin-based drugs. J Drug Delivery Sci Technol 55:101471.
   Web of Science ®Google Scholar
• Li H, Feng Y, Zheng X, et al. (2022). M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization. J Control Release 341:16–30.
   PubMed Web of Science ®Google Scholar
• Li J, Chen L, Xu X, et al. (2020). Targeted combination of antioxidative and anti-inflammatory therapy of rheumatoid arthritis using multifunctional dendrimer-entrapped gold nanoparticles as a platform. Small 16:2005661.
   Web of Science ®Google Scholar
• Lin X, Xie J, Niu G, et al. (2011). Chimeric ferritin nanocages for multiple function loading and multimodal imaging. Nano Lett 11:814–9.
   PubMed Web of Science ®Google Scholar
• Liu L, Hu F, Wang H, et al. (2019). Secreted protein acidic and rich in cysteine mediated biomimetic delivery of methotrexate by albumin-based nanomedicines for rheumatoid arthritis therapy. ACS Nano 13:5036–48.
   PubMed Web of Science ®Google Scholar
• Look J, Wilhelm N, von Briesen H, et al. (2015). Ligand-modified human serum albumin nanoparticles for enhanced gene delivery. Mol Pharm 12:3202–13.
   PubMed Web of Science ®Google Scholar
• Lyu J, Wang L, Bai X, et al. (2021). Treatment of rheumatoid arthritis by serum albumin nanoparticles coated with mannose to target neutrophils. ACS Appl Mater Interfaces 13:266–76.
   PubMed Web of Science ®Google Scholar
• Mi FL, Burnouf T, Lu SY, et al. (2017). Self-targeting, immune transparent plasma protein coated nanocomplex for noninvasive photothermal anticancer therapy. Adv Healthcare Mater 6:1700181.
   Web of Science ®Google Scholar
• Mosser DM, Zhang X. (2008). Interleukin-10: new perspectives on an old cytokine. Immunol Rev 226:205–18.
   PubMed Web of Science ®Google Scholar
• Oray M, Abu Samra K, Ebrahimiadib N, et al. (2016). Long-term side effects of glucocorticoids. Expert Opin Drug Saf 15:457–65.
   PubMed Web of Science ®Google Scholar
• Pandey S, Mahtab A, Rai N, et al. (2017). Emerging role of CD44 receptor as a potential target in disease diagnosis: a patent review. Recent Pat Inflamm Allergy Drug Discov 11:77–91.
   PubMed Web of Science ®Google Scholar
• Patel HM, Moghimi SM. (1998). Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system - the concept of tissue specificity. Adv Drug Deliv Rev 32:45–60.
   PubMed Web of Science ®Google Scholar
• Quan L, Zhang Y, Dusad A, et al. (2016). The evaluation of the therapeutic efficacy and side effects of a macromolecular dexamethasone prodrug in the collagen-induced arthritis mouse model. Pharm Res 33:186–93.
   PubMed Web of Science ®Google Scholar
• Rall LC, Rosen CJ, Dolnikowski G, et al. (1996). Protein metabolism in rheumatoid arthritis and aging. Effects of muscle strength training and tumor necrosis factor alpha. Arthritis Rheum 39:1115–24.
   PubMed Web of Science ®Google Scholar
• Ren H, He Y, Liang J, et al. (2019). Role of liposome size, surface charge, and PEGylation on rheumatoid arthritis targeting therapy. ACS Appl Mater Interfaces 11:20304–15.
   PubMed Web of Science ®Google Scholar
• Sparks JA. (2019). Rheumatoid arthritis. Ann Intern Med 170:ITC1–itc16.
   PubMed Web of Science ®Google Scholar
• Tan T, Huang Q, Chu W, et al. (2022). Delivery of germacrone (GER) using macrophages-targeted polymeric nanoparticles and its application in rheumatoid arthritis. Drug Deliv 29:692–701.
   PubMed Web of Science ®Google Scholar
• Teng MW, Darcy PK, Smyth MJ. (2011). Stable IL-10: a new therapeutic that promotes tumor immunity. Cancer Cell 20:691–3.
   PubMed Web of Science ®Google Scholar
• Tian L, Chen Q, Yi X, et al. (2017). Radionuclide I-131 labeled albumin-paclitaxel nanoparticles for synergistic combined chemo-radioisotope therapy of cancer. Theranostics 7:614–23.
   PubMed Web of Science ®Google Scholar
• van der Woude D, van der Helm-van Mil AHM. (2018). Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol 32:174–87.
   PubMed Web of Science ®Google Scholar
• Vandewalle J, Luypaert A, De Bosscher K, et al. (2018). Therapeutic mechanisms of glucocorticoids. Trends Endocrinol Metab 29:42–54.
   PubMed Web of Science ®Google Scholar
• Wang Q, Jiang J, Chen W, et al. (2016). Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis. J Control Release 230:64–72.
   PubMed Web of Science ®Google Scholar
• Wang Q, Sun X. (2017). Recent advances in nanomedicines for the treatment of rheumatoid arthritis. Biomater Sci 5:1407–20.
   PubMed Web of Science ®Google Scholar
• Wang Y, Smith W, Hao D, et al. (2019). M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds. Int Immunopharmacol 70:459–66.
   PubMed Web of Science ®Google Scholar
• Wei X, Wu J, Zhao G, et al. (2018). Development of a janus kinase inhibitor prodrug for the treatment of rheumatoid arthritis. Mol Pharm 15:3456–67.
   PubMed Web of Science ®Google Scholar
• Yan F, Li H, Zhong Z, et al. (2019). Co-delivery of prednisolone and curcumin in human serum albumin nanoparticles for effective treatment of rheumatoid arthritis. Int J Nanomedicine 14:9113–25.
   PubMed Web of Science ®Google Scholar
• Zhao P, Wang Y, Wu A, et al. (2018). Roles of albumin-binding proteins in cancer progression and biomimetic targeted drug delivery. Chembiochem 19:1796–805.
   PubMed Web of Science ®Google Scholar
• Zhong J, Zhang Q, Zhang Z, et al. (2022). Albumin mediated reactive oxygen species scavenging and targeted delivery of methotrexate for rheumatoid arthritis therapy. Nano Res 15:153–61.
   Web of Science ®Google Scholar